Paper Details
- Home
- Paper Details
The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients with 95.3% Follow-up: a Multicenter Study.
Author: BelnapLegrand, CottamDaniel, MedlinWalter, PottsJames, RichardsChristina, RoslinMitchell, SurveAmit, UchalMiro
Original Abstract of the Article :
BACKGROUND: Thromboprophylaxis in bariatric surgery is widely debated; however, few large articles evaluate treatment plans and their efficacy. Herein, we make the first large-scale report of the safety and efficacy of apixaban (Eliquis) for thrombus prevention following bariatric surgery. PURPOSE:...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1007/s11695-022-06051-7
データ提供：米国国立医学図書館（NLM）
Apixaban: A Safe Oasis in the Desert of Post-Bariatric Thromboprophylaxis
The world of bariatric surgery is a complex and evolving desert, with many challenges to overcome. This research explores the safety and efficacy of apixaban (Eliquis) for thromboprophylaxis in patients undergoing bariatric surgery. The authors conducted a large-scale retrospective analysis of 5017 patients who received apixaban post-bariatric surgery, evaluating its effectiveness in preventing thromboembolic events.
A Safe and Effective Oasis in the Desert of Bariatric Surgery
This research suggests that apixaban is a safe and effective option for thromboprophylaxis in patients undergoing bariatric surgery. The authors found that apixaban was associated with minimal side effects and effectively prevented thromboembolic events in patients who adhered to the prescribed protocol. This is like finding a safe and refreshing oasis in the desert of bariatric surgery, providing a potentially valuable tool for managing the risks associated with this complex procedure.
A More Sustainable Journey Through Bariatric Surgery
This research provides valuable insights into the safety and efficacy of apixaban in managing thromboprophylaxis after bariatric surgery. The findings suggest that apixaban could be a valuable tool for improving patient outcomes while minimizing complications. It's a step towards creating a more sustainable journey through the desert of bariatric surgery, offering a potentially safer and more effective approach to managing this complex procedure.
Dr.Camel's Conclusion
This research provides a comprehensive assessment of the safety and efficacy of apixaban for thromboprophylaxis in post-bariatric surgery patients. The findings offer a promising alternative for managing the risks associated with this procedure, potentially improving patient outcomes while minimizing complications. It's a journey through the desert of bariatric surgery, and this research sheds light on a potential oasis, offering a safer and more effective path to recovery.
Date :
- Date Completed 2022-07-14
- Date Revised 2022-07-14
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.